content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001837016</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001601830</issuerCik>
        <issuerName>RECURSION PHARMACEUTICALS, INC.</issuerName>
        <secFileNumber>001-40323</secFileNumber>
        <issuerAddress>
          <com:street1>41S RIO GRANDE STREET</com:street1>
          <com:city>SALT LAKE CITY</com:city>
          <com:stateOrCountry>UT</com:stateOrCountry>
          <com:zipCode>84101</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>(385) 269-0203</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Li Dean Y</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Director</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Class A</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Fidelity Brokerage Services LLC</name>
          <address>
            <com:street1>900 Salem Street</com:street1>
            <com:city>Smithfield</com:city>
            <com:stateOrCountry>RI</com:stateOrCountry>
            <com:zipCode>02917</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>29000</noOfUnitsSold>
        <aggregateMarketValue>396193.31</aggregateMarketValue>
        <noOfUnitsOutstanding>208283925</noOfUnitsOutstanding>
        <approxSaleDate>01/09/2024</approxSaleDate>
        <securitiesExchangeName>NASDAQ</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Class A</securitiesClassTitle>
        <acquiredDate>09/19/2017</acquiredDate>
        <natureOfAcquisitionTransaction>Founders Shares</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>29000</amountOfSecuritiesAcquired>
        <paymentDate>09/19/2017</paymentDate>
        <natureOfPayment>Compensation</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <remarks>This trade took place in the Dean Y Li 2021 Family Trust Agreement , of which Dean Y. Li is an Account Stakeholder</remarks>
      <noticeSignature>
        <noticeDate>01/09/2024</noticeDate>
        <planAdoptionDates>
          <planAdoptionDate>08/22/2023</planAdoptionDate>
        </planAdoptionDates>
        <signature>/s/ Courtney Broxterman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Dean Y Li</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 3093}]
text: 144
  0001837016
  XXXXXXXX
  LIVE
  0001601830
  RECURSION PHARMACEUTICALS, INC.
  001-40323
  41S RIO GRANDE STREET
  SALT LAKE CITY
  UT
  84101
  (385) 269-0203
  Li Dean Y
  Director
  Class A
  Fidelity Brokerage Services LLC
  900 Salem Street
  Smithfield
  RI
  02917
  29000
  396193.31
  208283925
  01/09/2024
  NASDAQ
  Class A
  09/19/2017
  Founders Shares
  Issuer
  N
  29000
  09/19/2017
  Compensation
  Y
  This trade took place in the Dean Y Li 2021 Family Trust Agreement , of which Dean Y. Li is an Account Stakeholder
  01/09/2024
  08/22/2023
  /s/ Courtney Broxterman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Dean Y Li